GlassScriptPhysician profile
James Ntambi
NPI 1669659959
$1,344.85
in general payments reported to CMS, 2019-2025
10 companies · $652 in 2025
The $652 reported for 2025 was more than what 79% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.33 · 2020: $110 · 2021: $32.54 · 2022: $58.37 · 2023: $127 · 2024: $312 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Consulting Fee: $160 · Travel and Lodging: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.39 |
| Consulting Fee | $160.00 |
| Travel and Lodging | $117.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $565.81 | 2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $171.40 | 2023-2024 | Pylarify |
| Lantheus Medical Imaging, INC. | $160.00 | 2024 | |
| Ge Healthcare | $159.01 | 2021-2025 | |
| Amgen INC. | $110.00 | 2020 | |
| Siemens Medical Solutions USA, INC. | $70.92 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $33.66 | 2023 | |
| Pfizer INC. | $29.78 | 2025 | |
| Blue Earth Diagnostics | $24.12 | 2022 | |
| Curium US LLC | $20.15 | 2025 | Detectnet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ntambi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.